Robert Lafyatis: Clinical Trials

1 trial sponsored by Robert Lafyatis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Robert Lafyatis: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Dimethyl Fumarate (DMF), Placebo Oral Tablet - Systemic Sclerosis, Pulmonary; Hypertension
Phase 1TerminatedRobert Lafyatis62016-12-012022-03-17

Conditions studied

Hypertension, Pulmonary (1)  ·  Scleroderma, Diffuse (1)  ·  Scleroderma, Systemic (1)

Interventions

Dimethyl Fumarate (1)

Countries

United States (1)

Top investigators

Robert A Lafyatis, MD (1)